Single Dose PG102 in Patients With Active Psoriatic Arthritis

NCT00787137 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped poor recruitment

Conditions

Arthritis, Psoriatic

Interventions

DRUG: PG102
DRUG: Placebo comparator

Sponsor

PanGenetics UK Limited